M42 and Mubadala Bio’s GMSC Sign Exclusive Outsourcing Agreement for Medical Supply Chain Resilience and Operational Strength

• The agreement will deliver end-to-end medical supply chain solutions across M42’s network, strengthening in-country capabilities and supply chain resilience in support of the UAE’s ambitions.

Abu Dhabi, UAE, 8 May 2026: M42, a global health leader powered by artificial intelligence (AI), technology and genomics, and Global Medical Supply Chain (GMSC), a subsidiary of Mubadala Bio, a life sciences company committed to advancing better health outcomes for the UAE and beyond, have entered into an outsourcing agreement to strengthen medical supply chain services across M42’s healthcare network.

Continue reading M42 and Mubadala Bio Enhance UAE Healthcare with Supply Chain Agreement →